Control over the underlying formulation process requires an issued U.S. utility patent. Application US-20220370531-A1 remains a pending publication. A pending application gives Landrace Bioscience priority dating, but it grants zero legal authority to stop U.S. competitors from manufacturing or selling similar formulations until a patent is officially granted by the USPTO.
Landrace Bio---owns the brand trademark for the RELIEFTA Products, they have another brand trademark, (TODDVILLE) no products are associated with this brand at this time!!!! 11Three LLC or UNIVEC (UNVC) hold no direct recorded title to the trademarks or patent on the federal register, relying entirely on internal licensing agreements or corporate relationships.
PL
Source: https://investorshangout.com/post/viewremoved?id=6842779